Fu Yu, Fan Yihua, Fan Wei, Lv Yubing, Ai Siyu, Yu Chenghao
Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan province.
Ethnic Medicine Research Institute of Southeast of Guizhou province, Kaili, Guizhou province.
Medicine (Baltimore). 2020 Sep 4;99(36):e22039. doi: 10.1097/MD.0000000000022039.
Clinical studies found that the combination of traditional Chinese herbal formula, and western medicine therapy are better in shrinking fibroids and improve other symptoms. This study aims to systematically evaluate the efficacy and safety traditional Chinese herbal formula combined with western medicine in the treatment of uterine fibroids.
Randomized controlled trials of traditional Chinese herbal formula combined with western medicine for uterine fibroids patients will be searched in PubMed, Medline, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Chongqing VIP Chinese Science and Technology Periodical Database, Chinese Biological and Medical database (CMB), and Wanfang database from inception to August 2020. Two researchers will perform data extraction and risk of bias assessment independently. Statistical analysis will be conducted in RevMan 5.3.
This study will summarize the present evidence by exploring the efficacy and safety of traditional Chinese herbal formula combined with western medicine in the treatment of uterine fibroids CONCLUSIONS:: The findings of the study will help to determine potential benefits of traditional Chinese herbal formula combined with western medicine in the treatment of uterine fibroids.
The private information from individuals will not be published. This systematic review also will not involve endangering participant rights. Ethical approval is not required. The results may be published in a peer-reviewed journal or disseminated in relevant conferences.
DOI 10.17605/OSF.IO/XUA8V.
临床研究发现,中药配方与西医治疗相结合在缩小子宫肌瘤和改善其他症状方面效果更佳。本研究旨在系统评价中药配方联合西医治疗子宫肌瘤的疗效和安全性。
从创刊至2020年8月,在PubMed、Medline、Embase、Cochrane图书馆、中国知网(CNKI)、重庆维普中文科技期刊数据库、中国生物医学数据库(CMB)和万方数据库中检索中药配方联合西医治疗子宫肌瘤患者的随机对照试验。两名研究人员将独立进行数据提取和偏倚风险评估。将在RevMan 5.3中进行统计分析。
本研究将通过探讨中药配方联合西医治疗子宫肌瘤的疗效和安全性来总结现有证据。结论:本研究结果将有助于确定中药配方联合西医治疗子宫肌瘤的潜在益处。
不会公布个人隐私信息。本系统评价也不会涉及危及参与者权利的问题。无需伦理批准。研究结果可能发表在同行评审期刊上或在相关会议上传播。
开放科学框架(OSF)注册号:DOI 10.17605/OSF.IO/XUA8V。